Upper Respiratory Staph/Strep Combination (Deseret Biologicals, Inc.)


Welcome to the PulseAid listing for the Upper Respiratory Staph/Strep Combination drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc.
NON-PROPRIETARY NAME: Staphylococcus Aureus, Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Streptococcus Viridans
SUBSTANCE NAME: STAPHYLOCOCCUS AUREUS; KLEBSIELLA PNEUMONIAE; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; HAEMOPHILUS INFLUENZAE TYPE B; STREPTOCOCCUS VIRIDANS GRO
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-05-31
END MARKETING DATE: 0000-00-00


Upper Respiratory Staph/Strep Combination HUMAN OTC DRUG Details:

Item DescriptionUpper Respiratory Staph/Strep Combination from Deseret Biologicals, Inc.
LABELER NAME: Deseret Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 12; 12; 12; 12; 12; 36([hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1)
START MARKETING DATE: 2017-05-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43742-1015_226680c4-9ec4-4bbf-911b-ae4124e352db
PRODUCT NDC: 43742-1015
APPLICATION NUMBER:

Other STAPHYLOCOCCUS AUREUS; KLEBSIELLA PNEUMONIAE; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; HAEMOPHILUS INFLUENZAE TYPE B; STREPTOCOCCUS VIRIDANS GRO Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Upper Respiratory Staph Strep Combination